Cencora, Inc.
Financials
Valuation Metrics
Cencora, Inc.'s Market Cap is $60.18B. At end of 2025 it was $65.49B. Ranked #277 of 3,121 in US market (top 9%), #202 of 1,658 on NYSE (top 12%), #14 of 205 in Health Care Equipment & Services (top 7%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $60.18B | US#277/3,121 Sec#14/205 |
| Revenue | $332.77B | US#11/3,121 Sec#4/205 |
| Net Income | $2.62B | US#280/3,121 Sec#14/205 |
| Total Assets | $83.81B | US#212/3,121 Sec#10/205 |
| Net Assets | $3.05B | US#959/3,121 Sec#49/205 |
| Employees | 47,000 | US#268/3,121 Sec#25/205 |
| Value | ||
| P/E | 22.93x | US#1,313/3,121 Sec#40/205 |
| P/B | 19.72x | US#2,792/3,121 Sec#178/205 |
| PEG | 0.60x | US#672/3,121 Sec#29/205 |
| P/S | 0.18x | US#81/3,121 Sec#6/205 |
| EV/EBITDA | 13.46x | US#1,355/3,121 Sec#48/205 |
| FCF Yield | 6.75% | US#1,062/3,121 Sec#47/205 |
| Profitability | ||
| ROE | 86.03% | US#36/3,121 Sec#4/205 |
| ROA | 3.13% | US#1,396/3,121 Sec#88/205 |
| Op. Margin | 1.30% | US#2,281/3,121 Sec#127/205 |
| Revenue Growth | 5.09% | US#1,802/3,121 Sec#132/205 |
| Earnings Growth | 38.35% | US#604/3,121 Sec#33/205 |
| Financial Health | ||
| Debt Ratio | 2640.69% | US#2,880/3,121 Sec#192/205 |
| Total Debt | $11.72B | US#366/3,121 Sec#19/205 |
| FCF | $4.06B | US#197/3,121 Sec#15/205 |
| Cash | $2.82B | US#318/3,121 Sec#17/205 |
| Current Ratio | 0.93x | US#2,350/3,121 Sec#191/205 |
| Net Debt/EBITDA | 1.74x | US#1,226/3,121 Sec#72/205 |
| Dividend | ||
| Div. Yield | 0.78% | US#1,419/3,121 Sec#34/205 |
| Div. Growth | 7.56% | US#642/3,121 Sec#22/205 |
| Performance | ||
| 1Y Return | 7.36% | US#1,548/3,121 Sec#112/205 |
| 1M Return | -2.16% | US#1,241/3,121 Sec#111/205 |
| From 52W High | -17.94% | US#1,353/3,121 Sec#93/205 |
| 1Y MDD | -32.44% | US#1,586/3,121 Sec#77/205 |
| Trading | ||
| Volume | 716,162 shares | US#1,687/3,121 Sec#108/205 |
| Trading Value | $224M | US#417/3,121 Sec#35/205 |
| Per Share | ||
| EPS | $13.49 | US#180/3,121 Sec#14/205 |
| BPS | $15.68 | US#1,485/3,121 Sec#81/205 |
Company Info
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.